The Autogenous Vaccine For Aquaculture Market To Witness A Slump, Reach Merely U

Posted by Ashish on April 8th, 2021

Fish is a widely consumed food across the world. In 2019, 177.8 million metric tons of fish were produced globally. In spite of such huge production in aquaculture, bacterial disease is a major issue, and is causing multibillion-dollar losses annually. In developing countries, fish diseases often spread quickly between small-scale aquaculture farms. Rising prevalence of infectious diseases such as bacterial diseases, viral diseases, and parasitic and fungal diseases amongst fish species remains a global issue for fish farmers.

Autogenous vaccines have been playing a vital role in bacterial disease control in aquaculture. This is the most effective method for preventing a wide range of bacterial and viral diseases. Autogenous vaccines are widely accepted by aquaculture farming companies during emergency outbreaks, due to very few commercial vaccines being available for specific aquaculture-related diseases.

According to the latest report published by Persistence Market Research, the global autogenous vaccine for aquaculture market was valued at US$ 11 Mn in 2020, and is expected to witness a CAGR of 5.5% during the forecast period (2020 – 2030).

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/32293

Companies covered in Autogenous Vaccine For Aquaculture Market Report

  • IDT Biologika GmbH (Ridgeway Biologicals Ltd)
  • MARINNOVAC (AQUATRECK ANIMAL HEALTH S.L.)
  • Ceva Biovac
  • Zoetis (PHARMAQAS)
  • Vaxxinova
  • Barramundi Asia Pte Ltd.(UVAXX Asia)
  • HIPRA
  • AniCon Labor GmbH
  • sanphar (ipeve)
  • Kennebec River Biosciences

Like it? Share it!


Ashish

About the Author

Ashish
Joined: September 12th, 2019
Articles Posted: 582

More by this author